Physician profile
Joseph E Pierse
NPI 1730486630
$985.17
in general payments reported to CMS, 2019-2025
8 companies · $469 in 2025
The $469 reported for 2025 was more than what 77% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.54 · 2020: $63.33 · 2021: $19.65 · 2022: $84.00 · 2023: $152 · 2024: $125 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621 · Gift: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.67 |
| Gift | $124.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $289.88 | 2023-2025 | Implant Dentistry, Astra Tech Implant System |
| Ultradent Products INC | $124.98 | 2024 | Opalescence |
| Nobel Biocare USA | $114.14 | 2019-2023 | Nobelactive |
| Kls-Martin L.P. | $112.06 | 2019-2022 | |
| Straumann USA LLC | $100.34 | 2020-2025 | |
| Geistlich Pharma, North America, INC. | $85.21 | 2025 | Biomaterials |
| Zimvie INC. | $85.09 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $73.47 | 2023 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Pierse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.